The PurpleLab®

Dr. Russell Robbins

News

Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…

Articles

Creating a holistic direct to consumer (DTC) and healthcare provider (HCP) marketing strategy from scratch is a demanding task, especially if you don’t have the clinical expertise to precisely identify the consumers or providers you should be targeting. We’re here to give you 5 simple steps to creating a holistic DTC and HCP targeting strategy…

Articles

The research is clear: Data drives better health outcomes.  Data has the power to transform how healthcare is delivered and guide organizations toward more patient-centered, value-driven care. Even though data is abundant, it’s often siloed or delivered in disparate data sets, and companies commonly lack the necessary resources to turn the data into insights.   Making…

Videos

PurpleLab Accelerates Clinical Trial Lifecycle with Real-World-Data This video was created in collaboration with the Applied Clinical Trials. Approximately 80% of clinical trials will face delays at some point in the trial process. Jason Gagner talked with ACT about how PurpleLab uses real-world data to better inform trials and improve their success rates. Learn More About: Utilizing…

News

This study was run to determine if a racial disparity exists in biomarker testing for NSCLC (non-small cell lung cancer) patients. Jared Safran, PharmD, MS, Russell Robbins, MD, MBA, Maggie Mendes, Douglas Londono, PhD, Grace Kane, MS. Healthcare is evolving into precision medicine or what the FDA refers to as personalized medicine1. This targeted approach…

Solution Sheets

PurpleLab’s® Clinical Trial data provides detailed metrics on clinical trial activities performed by healthcare providers (HCPs) and healthcare organizations (HCOs). By integrating clinical trial data, overall profiles of HCPs and HCOs are enhanced, offering a clearer view of a provider’s clinical research experience. With this added visibility, users can efficiently segment and identify potential investigators and…

News

This study was run to evaluate whether provider specialty is a driver for biosimilar adoption, defined as adoption probability difference (APD). Diane Faraone, PharmD, Russell Robbins, MD, MBA, Grace Kane, MS, Douglas Londono, PhD.  The US biologics market has significantly expanded in recent years; projected to reach $62 billion in prescription drug spend by 2025. Biosimilar…

News

Study is to assess the SARS-CoV-2 antibody levels over time (2021-2022), measured with the Elecsys Anti-SARS-COV-2 S assay, in the real-world setting, and assess the association between them and subsequent COVID-19 outcomes. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon presented a poster during ISPE 2024. The objective of this…

Solution Sheets

PurpleLab® goes further than raw claims data, by serving longitudinal patient data in combination with our no-code HealthNexus platform, to deliver on-demand insights, in minutes. HealthNexus, harmonizes the complex intersections created by the array of disparate healthcare vocabularies that annotate the factual account of a patient’s journey along with the reporting dimensions of critical need….

Webinars

Join PurpleLab and XO Health with Fierce Healthcare for an engaging discussion that melds data analytics and setting up for success with a value-based care model. The shift to a value-based care model has been a topic across the healthcare ecosystem for years now- but what will actually make that shift possible for payers and…

Webinars

Join us for a comprehensive webinar that explores how to revolutionize your clinical trial process from start to finish. Discover how data-driven strategies and innovative solutions can enhance each phase of your clinical trials, leading to optimal outcomes. Whether you’re initiating a new study or looking to optimize ongoing trials, this webinar will provide valuable…